Claims
- 1. A chewable tablet comprising an ingredient requiring taste masking and an effective amount of hydrolyzed gelatin to mask the taste of said ingredient and enhance the flavor of the chewable tablet, wherein said hydrolyzed gelatin is present in an amount of between 2 and 30 mg in said chewable tablet.
- 2. The chewable tablet of claim 1 wherein the ingredients requiring taste masking are chosen from the group consisting of medicinals and nutritional supplements.
- 3. The chewable tablet of claim 2 wherein the medicinals requiring taste masking are chosen from the group consisting of antacids, analgesics, H.sub.2 blockers, and minerals.
- 4. The chewable tablet of claim 2 wherein the nutritional supplement includes a mineral component requiring taste masking.
- 5. A method of making a chewable tablet comprising the steps of:
- a. combining ingredients requiring taste masking, and an effective amount of hydrolyzed gelatin to mask the taste of said ingredient and enhance the flavor of the chewable tablet, wherein said hydrolyzed gelatin is present in an amount of between 2 and 30 mg in said chewable tablet;
- b. blending the combined components; and
- c. tableting.
- 6. The chewable tablet of claim 1 wherein said gelatin is present in an amount of between 2 and 20 mg per tablet.
- 7. The chewable tablet of claim 6 wherein said gelatin is present in an amount of between 2 and 10 mg per tablet.
- 8. The chewable tablet of claim 7 wherein said gelatin is present in an amount of about 3 mg per tablet.
- 9. The chewable tablet of claim 2 wherein said nutritional supplement is a vitamin.
- 10. The chewable tablet of claim 2, wherein the medicinal is an expectorant.
- 11. The chewable tablet of claim 3, wherein the medicinal is an analgesic selected from the group consisting of acetaminophen and non-steroidal anti-inflammatories.
- 12. The chewable tablet of claim 11, wherein the non-steroidal anti-inflammatory is selected from the group consisting of aspirin, ibuprofen, ketoprofen and naproxen.
- 13. The chewable tablet of claim 3, wherein the medicinal is an H.sub.2 blocker selected from the group consisting of cimetidine, ranitidine and famotidine.
- 14. The chewable tablet of claim 3, wherein the medicinal requiring taste masking is a mineral selected from the group consisting of calcium and iron.
- 15. A chewable nutritional supplement tablet which requires taste masking and an effective amount of hydrolyzed gelatin to mask the taste of said chewable tablet and enhance the flavor of said chewable tablet wherein said hydrolyzed gelatin is present in an amount of between 2 and 30 mg in said chewable tablet.
- 16. The chewable nutritional supplement tablet of claim 15 wherein said gelatin is present in an amount of between 2 and 20 mg per tablet.
- 17. The chewable antacid tablet of claim 16 wherein said gelatin is present in an amount of between 2 and 10 mg per tablet.
- 18. The chewable nutritional supplement tablet of claim 17 wherein said gelatin is present in an amount of about 3 mg per tablet.
- 19. The chewable nutritional supplement tablet of claim 15, wherein said nutritional supplement is a vitamin.
- 20. The chewable nutritional supplement tablet of claim 15, wherein said tablet comprises a mineral requiring taste masking.
- 21. The chewable nutritional supplement tablet of claim 20, wherein said mineral is selected from the group consisting of calcium and iron.
Parent Case Info
This application is a continuation of application Ser. No. 08/434,835, filed May 4, 1995, which is a continuation of application Ser. No. 08/283,675, filed Aug. 1, 1994 ; which is a continuation of application Ser. No. 08/107,202,filed Aug. 13, 1993, both now abandoned.
US Referenced Citations (22)
Non-Patent Literature Citations (3)
Entry |
O. Kinnunen and J. Salokannel, "Constipation in Elderly Long-Stay Patients: Its Treatment by Magnesium Hydroxide and Bulk-Laxative," Annuals of Clinical Research, 19:321-323, (1987). |
Herbert A. Lieberman et al, "Pharmaceutical Dosage Forms: Tablets," Marcel Dekker, Inc., vol. 1, 2nd Ed., pp. 160-163. |
Remington Pharmaceutical Science, pp. 1605-1606, Mack Publishing Co., 1985. |
Continuations (3)
|
Number |
Date |
Country |
Parent |
434835 |
May 1995 |
|
Parent |
283675 |
Aug 1994 |
|
Parent |
107202 |
Aug 1993 |
|